4E‐BP1 is a well‐validated downstream target whose phosphorylation is modulated based on the activation of the PI3K/AKT/mTOR signaling pathway, a pathway that is frequently activated in numerous cancers, including GC (Fruman and Rommel, 2014; Tapia et al., 2014). Here, MTOR is linked to cancer.